References
- Huang M. E., Ye Y. C., Chen S. R. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukaemia. Blood 1988; 72: 567–572
- Castaigne S., Chomienne C., Daniel M. T., Berger R., Fenaux P., Degos L. All-trans retinoic acid as differentiation therapy for acute promyelocytic leukaemia. I. Clinical Results. Blood 1990; 76: 1704–1709
- Warrell R. P., Frankel S. R., Miller W. H., et al. Differentiation therapy of acute promyelocytic leukaemia with tretinoin (all-trans retinoic acid). N. Engl. J. Med. 1991; 374: 1385–1393
- Eardley A. M., Heller G., Warrell R. P. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukaemia. Leukemia June, 1994; Vol. 8(No. 6)934–939
- Frankel S. R., Eardley A., Lauwers G., Weiss M., Warrell R. P. The “retinoic acid syndrome” in acute promyelocytic leukaemia. Annals of Internal Medicine 1992; 117: 292–296
- Horikoshi A., Sawada S., Aiso M., Kawamura M., Iizuka Y., Takeuchi J., Ohshima T., Horie T., Nare T., Ohno R. A “retinoic acid syndrome” observed in two cases of acute promyelocytic leukaemia. Rinsho-Ketsueki Sep., 1993; 34(9)1044–9
- Warrell R. P., Maslak P., Eardley A., Heller G., Miller W. H., Frankel S. R. Treatment of Acute Promyelocytic Leukaemia with All-Trans Retinoic Acid: An Update of the New York Experience. Leukaemia June, 1994; Vol. 8(No. 6)929–933